WYC-209

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameWYC-209
Drug Alias NameWYC-209
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor beta agonistsRetinoic acid receptor alpha agonistsRetinoic acid receptor gamma agonists
TargetsRetinoic acid receptor gammaRetinoic acid receptor betaRetinoic acid receptor alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Organic ChemistryHuazhong University Of Science And TechnologyChengdu Baiyu Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Baiyu Pharma Co LtdHuazhong University Of Science And TechnologyShanghai Institute Of Organic Chemistry
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A